✦ LIBER ✦

Percutaneous Coronary Intervention With Second-Generation Paclitaxel-Eluting Stents Versus Everolimus-Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial)

✍ Scribed by Ron Waksman; Magdi Ghali; Randy Goodroe; Thomas Ryan; Mark Turco; Michael Ring; Thomas McGarry; David Dobies; Nicolas Shammas; Daniel H. Steinberg; Stacy Swymelar; Kimberly Kaneshige; Rebecca Torguson

Book ID: 119187342
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 641 KB
Volume: 110
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2012.05.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

TCT-328: Long-term outcome after percuta

TCT-328: Long-term outcome after percutaneous coronary intervention with titaniumnitride- oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a five-year follow-up of the TITAX-AMI trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB